Anti Mullerian Hormone Test Market Intelligence Report - Global Forecast to 2027

Anti Mullerian Hormone Test Market Intelligence Report - Global Forecast to 2027

The Global Anti Mullerian Hormone Test Market is projected to reach USD 422.58 million by 2027 from USD 221.65 million in 2021, at a CAGR 11.35% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Anti Mullerian Hormone Test Market size was estimated at USD 89.79 million in 2021 and expected to reach USD 99.08 million in 2022, at a CAGR 11.08% to reach USD 168.70 million by 2027.
• The Asia-Pacific Anti Mullerian Hormone Test Market size was estimated at USD 53.92 million in 2021 and expected to reach USD 60.74 million in 2022, at a CAGR 11.83% to reach USD 105.50 million by 2027.
• The Europe, Middle East & Africa Anti Mullerian Hormone Test Market size was estimated at USD 77.93 million in 2021 and expected to reach USD 86.57 million in 2022, at a CAGR 11.32% to reach USD 148.37 million by 2027.

Market Segmentation & Coverage:

The report on anti mullerian hormone test identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the anti mullerian hormone test to forecast the revenues and analyze the trends in each of the following sub-markets:

Product:

• POC Testing
• Self-check Kits
  • ELISA Kits
  • Rapid Test Kit

End-User:

• Commercial Labs
• Research & development

Distribution:

• Offline Channels
• Online Channels

Use:

• Human
• Non-Human

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbexa Ltd.
• Ansh Labs
• BioMérieux SA
• CTK Biotech, Inc.
• Cusabio Technology LLC
• Danaher Corporation
• Doctorcall Limited
• Eagle Biosciences, Inc.
• Elabscience, Inc.
• enQuire Bio, LLC
• F. Hoffmann-La Roche AG
• Fertility 2 U Ltd
• Kamiya Biomedical Co
• LifeSpan BioSciences, Inc.
• London Gynaecology Ltd.
• Monobind Inc.
• Tosoh Corporation
• Walk-In Lab, LLC

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 221.65 million

Estimated Year Value: USD 246.41 million

Forecast Year Value: USD 422.58 million

CAGR (%): 11.35%.

Please Note: PDF & Excel + Online Access - 1 Year